Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and stroke.

Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, Beulens JW.

J Thromb Haemost. 2014 Jul;12(7):1028-34. doi: 10.1111/jth.12609. Epub 2014 Jun 19.

2.

Vitamin K status in healthy volunteers.

Theuwissen E, Magdeleyns EJ, Braam LA, Teunissen KJ, Knapen MH, Binnekamp IA, van Summeren MJ, Vermeer C.

Food Funct. 2014 Feb;5(2):229-34. doi: 10.1039/c3fo60464k.

PMID:
24296867
3.

Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.

van den Heuvel EG, van Schoor NM, Lips P, Magdeleyns EJ, Deeg DJ, Vermeer C, den Heijer M.

Maturitas. 2014 Feb;77(2):137-41. doi: 10.1016/j.maturitas.2013.10.008. Epub 2013 Oct 24.

PMID:
24210635
4.

Circulating species of matrix Gla protein and the risk of vascular calcification in healthy women.

Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Elias SG, Velthuis BK, de Jong PA, Beulens JW.

Int J Cardiol. 2013 Oct 15;168(6):e168-70. doi: 10.1016/j.ijcard.2013.08.062. Epub 2013 Aug 27. No abstract available.

5.

Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.

Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, Beulens JW.

Diabetes Care. 2013 Nov;36(11):3766-71. doi: 10.2337/dc13-0065. Epub 2013 Jul 22.

6.

Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.

Dalmeijer GW, van der Schouw YT, Vermeer C, Magdeleyns EJ, Schurgers LJ, Beulens JW.

J Nutr Biochem. 2013 Apr;24(4):624-8. doi: 10.1016/j.jnutbio.2012.02.012. Epub 2012 Jul 20.

PMID:
22819559
7.

Vitamin K intake and status are low in hemodialysis patients.

Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R, Magdeleyns EJ, Herfs M, Vermeer C, Laverman GD.

Kidney Int. 2012 Sep;82(5):605-10. doi: 10.1038/ki.2012.191. Epub 2012 May 30.

8.

Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects.

Theuwissen E, Cranenburg EC, Knapen MH, Magdeleyns EJ, Teunissen KJ, Schurgers LJ, Smit E, Vermeer C.

Br J Nutr. 2012 Nov 14;108(9):1652-7. doi: 10.1017/S0007114511007185. Epub 2012 Jan 31.

PMID:
22289649
9.

Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.

Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C, Jahnen-Dechent W, Ketteler M, Floege J, Schurgers LJ.

Am J Kidney Dis. 2012 Feb;59(2):186-95. doi: 10.1053/j.ajkd.2011.10.041. Epub 2011 Dec 9.

PMID:
22169620
10.

Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults.

Shea MK, O'Donnell CJ, Vermeer C, Magdeleyns EJ, Crosier MD, Gundberg CM, Ordovas JM, Kritchevsky SB, Booth SL.

J Nutr. 2011 Aug;141(8):1529-34. doi: 10.3945/jn.111.139634. Epub 2011 May 31.

11.

Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.

Schlieper G, Westenfeld R, Krüger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic T, Ketteler M, Vermeer C, Dimkovic N, Floege J, Schurgers LJ.

J Am Soc Nephrol. 2011 Feb;22(2):387-95. doi: 10.1681/ASN.2010040339.

12.

Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species.

Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewé RB, Brandenburg VM, Bekers O, Vermeer C.

Thromb Haemost. 2010 Oct;104(4):811-22. doi: 10.1160/TH09-11-0786. Epub 2010 Aug 5.

PMID:
20694284
13.

The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA.

Clin J Am Soc Nephrol. 2010 Apr;5(4):568-75. doi: 10.2215/CJN.07081009. Epub 2010 Feb 4.

14.
15.

Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates.

Keuren JF, Magdeleyns EJ, Bennaghmouch A, Bevers EM, Curvers J, Lindhout T.

Br J Haematol. 2007 Aug;138(4):527-33. Epub 2007 Jun 29.

PMID:
17608769
16.

Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.

Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J.

Br J Haematol. 2006 Aug;134(3):307-13. Erratum in: Br J Haematol. 2006 Nov;135(3):418. Keuren, Jeffery F W [corrected to Keuren, Jeffrey F W].

PMID:
16848773
17.

Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G, Gooren LJ, Rosing J.

J Clin Endocrinol Metab. 2003 Dec;88(12):5723-9.

PMID:
14671159
18.

Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.

Thomassen MC, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J.

Haematologica. 2003 Oct;88(10):1150-6.

Supplemental Content

Loading ...
Support Center